In line with previous observations in mice8, 9, 10 and humans,11,12 we report that GLP1R agonism by itself attenuates hepatic steatosis, and now also show that the addition of GIPR agonism even further reduces lipid accumulation in the liver. This evidence concerns the gene GIPR and fatty liver disease.